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proteins responsible for escorting RNA pol II to the pro-
moter. The most recent regulators to be characterized
are the coactivators, corepressors, and chromatin re-
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have been well characterized, the precise mechanisms
by which these different classes of factors coordinately
regulate transcription remain to be elucidated. To un-Decades of research have uncovered much of the mo-
lecular machinery responsible for establishing and cover some of these mechanisms, a number of recent
studies have tracked down the effects of specific cova-maintaining proper gene transcription patterns in eu-
karyotes. Although the composition of this machinery lent modifications of transcription factors in the initiation
and elongation phases of the RNA pol II transcriptionis largely known, mechanisms regulating its activity
by covalent modification are just coming into focus. cycle. The critical role of phosphorylation in the control
of gene expression has been amply documented (forHere, we review several cases of ubiquitination, su-
moylation, and acetylation that link specific covalent review see Brivanlou and Darnell, 2002). Here, we will
limit our review to other types of modifications suchmodification of the transcriptional apparatus to their
regulatory function. We propose that potential cas- as ubiquitination, sumoylation, and acetylation, which
remarkably all target lysine residues and have recentlycades of modifications serve as molecular rheostats
that fine-tune the control of transcription in diverse been identified as important modulators of transcription.
While multiple covalent modifications of histone tailsorganisms.
have been well characterized and shown to play a global
role in gene expression (for review see Berger, 2002;The temporal and spatial control of gene expression is
Jenuwein and Allis, 2001), we postulate that modifica-one of the most fundamental processes in biology, and
tion of nonhistone regulatory proteins (i.e., transcriptionwe now realize that it encompasses many layers of com-
factors) will play an equally important and perhaps moreplexity and intricate mechanisms. To begin understand-
specific role in directly modulating transcription. The fewing this process, researchers have identified and partly
case studies discussed here will highlight the functionalcharacterized the elaborate molecular apparatus re-
significance of various distinct covalent modificationssponsible for executing the control of gene expression.
in the process of transcriptional activation. While theThis regulatory machinery is a conglomerate of protein
consequences of individual modifications have begunfactors that function coordinately and in combinatorial
to be addressed, the greater challenge for the futurefashion to turn specific genes on and off. In multicellular
will be to understand how a sequential and possiblyorganisms such as humans, it is the selective expression
a combinatorial network of multiple modifications canof gene products in individual cell types that leads to
regulate gene expression either in a synergistic or antag-the rich diversity of tissues that have evolved to perform
onistic fashion. Moreover, working out how subtlehighly specialized functions in the body. For example,
changes of the transcriptional machinery can vastly alterwhile brain cells express a unique set of genes important
activation and repression in the context of the largefor brain function, liver cells have evolved to express a
battery of transcriptional initiation factors will be criticaldistinct set of genes important for liver function. To
to understanding how elaborate gene expression pat-achieve such exquisite control of gene expression, or-
terns in metazoan organisms are orchestrated.ganisms have dedicated a large percentage of their ge-
netic coding capacity to gene products that help deter-
mine the spatial and temporal transcription of specific The Role of Ubiquitin in Regulating Transcription
genes. Ubiquitin, a small, 76 amino acid polypeptide, is cova-
The molecular machinery responsible for controlling lently linked to lysine residues of target proteins via an
transcription by RNA polymerase II (RNA pol II) is consid- enzymatic cascade invoving E1 activating, E2 conjugat-
erably more complex than anyone had anticipated. Over ing, and E3 ligase enzymes (Hershko and Ciechanover,
twenty years of transcription biochemistry and genetics 1998). At first glance, it appeared that transcription fac-
has identified a battery of proteins (80) that aid or tors tagged with ubiquitin would simply be subjected to
abate RNA pol II access to specific regulatory DNA sites, the classic 26S proteasome-mediated degradation (see
called promoters, scattered throughout the genome Figure 2A). Thus, it was postulated that regulated degra-
where RNA synthesis initiates (see Figure 1A). The first dation of ubiquitinated transcription factors would be
of these regulatory factors to be discovered were the one way to dictate when a given transcriptional event
sequence-specific DNA binding transcriptional activa- is activated or deactivated. For example, the processing
tors. We now estimate that roughly 5%–10% of the and nuclear localization of the transcritpion factor NF-B
genes in the human genome encode this vast family of is controlled by signaling cascades that trigger multiple
transcription factors. Next to be characterized were the ubiquitin-coupled and proteasome-dependent degra-
general transcription factors, a set of highly conserved dation events (Hershko and Ciechanover, 1998). In fact,
RNA pol II itself is ubqitinated upon DNA damage, and
this modification is thought to regulate the proteasomal-*Correspondence: jmlim@uclink4.berkeley.edu
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Figure 1. Regulating the Transcriptional Initi-
ation Machinery by Lysine Modification
(A) Potential modification targets of transcrip-
tional regulatory proteins. Depicted are sev-
eral classes of regulatory factors that cooper-
ate to initiate mRNA synthesis at a typical
promoter. These include chromatin remodel-
ing complexes (green), coregulatory com-
plexes including coactivators and corepres-
sors (blue), sequence-specific transcriptional
activators (red), and the basal machinery in-
cluding RNA pol. II (yellow). The covalent link-
age of ubiquitin and acetyl groups to potential
transcription factors is outlined and putative
modifications yet to be identified are indicated
by question marks. Important protein-protein
interactions that may be affected by covalent
modifications are indicated by arrows.
(B) Lysine residues in transcription factors are
targets of different covalent modifications.
Depicted is a potential network of reversible
and dynamic lysine modifications of tran-
scription factors. Lysine residues (labeled K)
can serve as the amino acid targets of multi-
ple covalent modifications including sumo-
ylation (SUMO), ubiquitination (Ub), acetyla-
tion (Ac), and methylation (Me). An individual
lysine residue can only be conjugated by a single modification at a time; however, multiple lysine residues of a protein may be modified
simultaneously. Therefore, lysine residues may undergo sequential or cascades of covalent modifications, where modification of an individual
residue may influence the modification of a neighboring residue. Abbreviations: Nuc., nucleosome; RE, response element; Ac, acetyl; Me,
methyl; Ub, ubiquitin; E3, E3 ligase; HAT, histone acetyltransferase; HDAC, histone deacetylase; UBAC, ubiquitin activating/conjugating activity.
mediated degradation of RNA polymerase II during tran- nine, Met4 is ubiquitinated and subsequently destroyed
by the proteasome. In contrast, in rich media supple-scription-coupled repair (Lee et al., 2002; Woudstra et
al., 2002). Thus, proteasomal-dependent degradation of mented with methionine, ubiquitinated Met4 is stable
and functional at a distinct set of genes, called the SAMthe transcriptional machinery is clearly important for
numerous mechanisms of transcriptional regulation. genes, but fails to associate properly with the MET
genes (Kuras et al., 2002). The finding that posttransla-However, more recent experiments reveal that under
certain circumstances ubiquitination of transcription tional modification of Met4 by ubiquitin controls selec-
tive activation of one set of Met4-responsive genes andfactors, independent of proteolysis, is also required for
the activation function of some transcription factors, not another is remarkable and suggests that cells have
evolved elaborate mechanisms to coordinately controlsuggesting a more complex interplay between regu-
lators. gene expression but, at the same time, discriminate
between different pathways by subtle mechanisms weFor instance, transcription of the MET genes, which
encode enzymes for the biosynthesis of the the sulfur- have only begun to appreciate.
In addition to ubiquitin, components of the protea-containing amino acids methionine and cysteine, is co-
ordinately controlled by levels of S-adenosylmethionine some itself have also been implicated in the control of
gene expression. The 26S proteasome is composed of a(called SAM or AdoMet) in yeast cells. When levels of
SAM are low, the transcriptional activator Met4 activates 20S proteolytic barrel and a 19S regulatory sub complex.
Johnston and colleagues had previously shown that thetranscription of the genes responsible for methionine
biosynthesis. When intracellular levels of SAM rise, 19S regulatory complex is involved in transcriptional
elongation by RNA pol II (Ferdous et al., 2001). To furtherthese genes are switched off via ubiquitin-dependent
inactivation of Met4 by the E3 ligase SCFMet30. Two seem- investigate the role of the 19S particle in transcription,
Gonzalez et al. (2002) have recently reported that multi-ingly contradictory observations suggested that Met4
regulation by ubiquitin is likely to be complex. Rouillon et ple components of the 19S regulatory complex can be
recruited to the GAL1 gene when cells are grown in theal. (2000) described the inactivation of Met4 by SCFMet30-
dependent ubiqutination followed by degradation of presence of galactose. Strikingly, the recruitment of the
19S complex was shown to be independent of the 20SMet4 by the 26S proteasome (Rouillon et al., 2000). In
contrast, Kaiser et al. (2000) demonstrated that Met4 proteasome, suggesting that the 19S activation of the
GAL1 gene is unlikely to only involve proteolysis. Theinactivation by ubiquitin did not involve proteolysis of
Met4, but rather, ubiquitin directly modulates the tran- presence of the 19S sub complex at the GAL1-10 pro-
moter and GAL1 gene supports its potential role as ascriptional activation function of Met4 (Kaiser et al.,
2000). To reconcile these differences, Kuras et al. (2002) direct activator of transcription. However, precise mech-
anisms of 19S recruitment to promoters potentially in-recently reported that Met4 is most likely regulated by
both degradation-dependent and -independent mecha- volving ubiquitnated activators and the function of this
regulatory sub complex in transcriptional initiation and/nisms, depending on growth conditions of the cells (see
Figure 2B). In minimal media supplemented with methio- or elongation remain open areas for future investigation.
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Figure 2. Several Alternative Models De-
picting Mechanisms of Transcriptional Regu-
lation by Covalent Modification
(A) Ubiquitination of transcriptional activator
proteins. Sequence-specific DNA binding ac-
tivators can bind to and activate promoters
to a certain level. In an undefined manner,
monoubiquitination (mono-Ub) is proposed
to stimulate the transcriptional potency of ac-
tivator proteins. Ubiquitin moieties can also
be added as long homopolymeric chains, and
polyubiquitinated (poly-Ub) transcription fac-
tors are likely targeted for proteolytic diges-
tion by the 26S proteasome (depicted as a
trash can). Accordingly, ubiquitination can
potentially positively and negatively regulate
the function of a transcription factor and may
be used to precisely regulate the expression
of given regulatory pathway in a timely
fashion.
(B) Multiple consequences of Met4 regulation
by ubiquitin. Met4 activates expression of
many genes, including a set of genes encod-
ing enzymes for sulfur amino acid biosynthe-
sis (MET genes) and a distinct set of genes
required for the production of S-adenosyl-
methionine (SAM genes). The fate of ubiquiti-
nated Met4 is remarkably dependent on
growth conditions. In minimal media supple-
mented with methionine, ubiquitinated Met4
is targeted for degradation by the 26S protea-
some. In contrast, in rich media supple-
mented with methionine, ubiquitinated Met4
is stable. Strikingly, in rich media, ubiquiti-
nated Met4 is differentially recruited to and
activates the SAM gene promoters and is pre-
vented from association MET gene promot-
ers. The mechanism that prevents associa-
tion of ubiquitinated Met4 with the MET genes
under these conditions in not known and is
indicated by a question mark.
(C) A mechanism of sumoylation-dependent
activator regulation. A number of transcription factors are regulated by SUMO modification followed by sequestration in subnuclear structures
called PODs or ND10 bodies. When sequestered in such subnuclear compartments, transcription factors are unable to perform their regulatory
functions. Subsequent cleavage of SUMO off a given sequestered protein by a SUMO-specific protease allows release of the transcription
factor from the PODs, whereby they can resume their regulatory function at the promoter. This proposed cycle of SUMO modification of
transcription factors provides a molecular switch by which the cell can respond to alternative stimuli.
In addition to these studies, a number of groups have ubiquitin ligase, implicating a direct role for ubiquitna-
tion in transcriptional activation (Salghetti et al., 2001).probed the potential role of ubiquitination on the activity
of transactivation domains derived from mammalian vi- This study suggests that monoubiquitination may en-
hance the activity of transcription factors and that poly-ral and cellular activators. Several investigators ob-
served that often the most potent transcriptional activa- ubiquitination may subsequently signal destruction by
the 26S proteasome (see Figure 2A). In addition, manytors expressed in cells were also the most difficult to
detect by immunoblotting. Looking at this phenomenon deubiquitinating enzymes function to remove ubiquitin
from target proteins. Since ubiquitination is a reversiblein greater detail, Molinari et al. (1999) observed a positive
correlation between the potency of activation domains modification, there may be distinct cues that signal the
addition and removal of ubiquitin to and from a particularand proteasome-mediated degradation. In addition, Sal-
ghetti et al. (2000) found a striking overlap in several transcription factor. Subtle transition between the non-,
mono-, and polyubiquitinated states may act as an im-transcription factors between the amino acid sequences
involved in transcriptional activation and degradation. portant switch to turn on and off a particular trancription
factor. Perhaps under certain conditions, E3 processi-Together, these studies suggested that strong transcrip-
tional activators may be switched off by proteasome- vity factors limit the extent to which ubiquitin is attached
to a target, thereby regulating the transition from mono-mediated degradation. But again, one must ask, was
simple proteolysis all that was going on? The answer to polyubiquitination. Future studies of ubiquitination
intermediates of natural endogenous activators will beappears to be no. Looking at activation by the synthetic
activator LexA-VP16 in yeast cells, Tansey and col- crucial to substantiate the importance of this proposed
mechanism in vivo. In addition, uncovering the physio-leagues observed that direct fusion of ubiquitin to the
potent activator is able to bypass the need for a specific logical signals responsible for the activation-coupled
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degradation of transcriptional activators will help deter- A number of transcription factors regulated by sumoy-
lation have recently been described. For example, themine how such pathways are regulated.
transcription factor LEF1, a downstream effector of theNot only is the transcriptional machinery targeted by
Wnt signaling cascade, has been reported to undergoubiquitination, a number of recent reports indicate that
regulation by sequestration into nuclear bodies in similarcontained within the regulatory apparatus itself are en-
fashion to PML. Sachdev et al. (2001) reported thatzymes that can catalyze the addition of ubiquitin to vari-
LEF-1 associates with the SUMO E3 ligase PIASy. Thisous target proteins. Brower et al. (2002) recently re-
association is thought to stimulate sumoylation of LEF-1ported that the MED8 (also called ARC32) subunit of
and inhibit LEF1-mediated transactivation by sequestra-a mammalian cofactor complex is able to reconstitute
tion into nuclear bodies (Sachdev et al., 2001). The physi-ubiquitin ligase activity in vitro. Moreover, the MED8-
ological signals that might trigger release of LEF1 fromcontaining complex from rat liver nuclear extracts co-
these nuclear bodies remain to be elucidated, but pre-purified with an ubiquitin ligase activity is suggestive
sumably they will be triggered during the Wnt signalingof an endogenous association between a mammalian
cascade when LEF1 is activated. Another transcriptiontranscriptional cofactor and an ubiquitin ligase (Brower
factor regulated by sumoylation is Sp3, one of severalet al., 2002). In a related scenario, the largest subunit
members of the Sp1 family of GC box binding transcrip-of the Drosophila TFIID complex, dTAF1 (formerly
tional regulators. Two recent studies report that Sp3dTAFII250), has been shown to harbor E1 and E2 ubiqui-
activity is modulated by sumoylation of a specific lysinetin-activating/conjugating (UBAC) activities (Pham and
residue in an inhibitory domain of the protein (Ross etSauer, 2000). The dTAF1 UBAC activity is observed to
al., 2002; Sapetschnig et al., 2002). Sapetschnig et al.be important for dorsal-mediated transactivation and
(2002) found that sumoylation of Sp3 by the SUMO E3proposed to catalyze monoubiquitination of histone H1.
ligase PIAS1, one of several related SUMO E3 ligases,In an independent study, Albert et al. (2002) recently
inhibits the transactivation potential of Sp3. In additionidentified an E3 ligase activity within the CNOT4 subunit
to detecting sumoylation-dependent inhibition of Sp3of the CCR4-NOT transcriptional repressor complex.
activity, Ross et al. (2002) detect Sp3 at the nuclearThe function of the CNOT4 E3 ligase is proposed to
periphery and within nuclear dots in a sumoylation-catalyze ubiquitination of select components of the tran-
dependent manner. Together, these studies suggestscription initiation machinery. Taken together, these
that sumoylation-associated sequestration of transcrip-studies suggest that the transcriptional machinery itself
tion factors in subnuclear bodies may modulate the ac-harbors ubiquitin-modifying enzymes that may regulate
tivity of transcriptional activators and that some as yetthe activity of specific subunits of the regulatory appara-
unknown signaling event releases these factors to per-tus (see Figure 1A). However, deciphering the in vivo
form their functions.targets of such ubiquitin-modifying activities and eluci-
Are nuclear PODs merely storage compartments ofdating their effects on transcriptional activation and re-
nuclear proteins, or is the release of transcription factorspression remains a formidable and critical task.
from such sites regulated by physiological cues that are
important for transcription? Recent characterization ofSUMO Enters the Nucleus
the mammalian SUMO-1 protease SuPr-1 suggests that
Besides ubiquitination, a number of transcription factors
regulation of gene expression and nuclear POD forma-
have been documented to be modified by the small
tion is functionally linked. Best et al. (2002) report that
ubiquitin-related modifier (SUMO). Sumoylation, the SuPr-1 is localized to nuclear PODs, associates with and
process of conjugating SUMO, a 101 amino acid poly- hydrolyzes SUMO-1-modified forms of PML, resulting in
peptide, to target proteins is highly similar to that of the redistribution of POD-localized transcription factors
ubiquitination (Kim et al., 2002). Both ubiquitin and in the nucleus. The positive effect of SuPr-1 on activation
SUMO are covalently linked to lysine residues of target is shown to be dependent on PML, as it is lost in PML-
proteins and adopt similar tertiary structures. In contrast deficient mouse embryonic fibroblasts. These data sug-
to their structural similarities, the biological conse- gest that assembly of transcription factors in nuclear
quences of sumoylation versus ubiquitnation are appar- PODs is critical for their subsequent function as activa-
ently markedly distinct. Proteins tagged with SUMO do tors (see Figure 2C). Remarkably, SuPr-1 was also
not apparently undergo proteasomal-dependent degra- shown to activate Sp3-mediated transactivation by cat-
dation. Instead, sumoylation is often involved in direct- alyzing the removal of SUMO-1 from Sp3 (Ross et al.,
ing the subcellular localization and stabilization of tran- 2002). Expression of SuPr-1 redistributed Sp3 from con-
scription factors. For example, a number of sumoylated centrated nuclear dots and the nuclear periphery to dif-
transcription factors, including the promyelocytic leuke- fuse nuclear staining, allowing Sp3 to efficiently activate
mia gene product PML, have been detected in sub- transcription. Characterizing the biological context in
nuclear structures variously called PML oncogenic do- which these activities are modulated in health and dis-
mains (PODs), nuclear bodies, or ND10 structures. The ease will likely uncover novel modes of gene regulation
disruption of nuclear PODs observed in acute promyelo- as well as the molecular basis of certain diseases such
cytic leukemia suggests that PODs perform a critical as leukemia.
function in protecting against certain forms of leukemia. Studies by Courey and colleagues on the SUMO (also
Since PODs contain a number of sumoylated transcrip- called Smt3) modification of the Drosophila transcription
tion factors, it is thought that sumoylation targets spe- factor Dorsal has revealed that, like ubiquitnation, su-
cific transcription factors into specialized subnuclear moylation may modulate multiple activities of individual
bodies, thereby regulating their activity and function in transcription factors. Accumulation of Dorsal, a fly ho-
molog of vertebrate NF-B, is negatively regulated bytranscription (see Figure 2C).
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a cytoplasmic binding partner Cactus, in analogous gene promoters as measured by chromatin immunopre-
cipitation during early HSV infection. (F.J. Herrera andfashion to IB-mediated inhibition of NF-B. The cova-
lent modification of Dorsal by SUMO was initially found S.J. Triezenberg, personal communication). However,
the HSV genome is apparently unadorned by nucleo-to relieve Cactus-mediated repression of Dorsal, al-
lowing nuclear translocation and subsequent activation somes, suggesting that the function of HAT recruitment
in the case of VP16 may be to acetylate nonhistoneby Dorsal (Bhaskar et al., 2000). However, more recent
findings suggest that in addition to relieving Cactus- components of the transcriptional initiation machinery.
Unraveling the molecular mechanisms of HSV immedi-mediated repression, sumoylation may also enhance the
activation function of nuclear-localized Dorsal, possibly ate-early gene transcription should reveal the non-
histone substrates of these HAT activities that may beby disrupting its association with an unknown nuclear
repressor (Bhaskar et al., 2002). Furthermore, Bhaskar critical for VP16-dependent transactivation. Such mech-
anisms will likely be relevant to the regulation of cellularet al. (2002) have also implicated the specific sumoyla-
tion of Dorsal to its function in regulating the innate gene transcription as well. Thus, we anticipate that the
acetylation state of promoter recognition proteins asimmune response in Drosophila. Such regulation by co-
valent modification of transcription factors highlights well as other transcription factors will emerge as a rich
area of important future investigations into gene regula-the potential role of modification dynamics in determin-
ing the biological output of the regulatory machinery. tory pathways.
Although we have not included a discussion here,Physiologic signals that increase or decrease the extent
of sumoylation may thus have a significant influence nonhistone methylation is also likely to play a role in
transcriptional regulation. In fact, the regulatory activi-on the activity of select transcription factors. Future
characterization of the functional significance of such ties of CBP/p300 were recently demonstrated to be
modulated by arginine methylation (Xu et al., 2001). Itregulatory marks will undoubtedly yield novel modes of
transcriptional regulation. is thus likely that histone methyltransferases, like acetyl-
transferases, will also be found to target nonhistone
regulatory proteins and modulate their function accord-Acetylation of Nonhistone Targets
ingly.In addition to ubiqitination and sumoylation, lysine resi-
dues of regulatory proteins can be covalently modified
by acetylation. The acetylation state of lysine residues Gridlock at Lysine Residues
Since ubiquitination, sumoylation, and acetylation canon histone tails has been well documented (for review
see Berger, 2002; Jenuwein and Allis, 2001). In contrast, all occur on lysine residues, transcription factors can
potentially undergo a cascade of modifications thatmuch less is known about the nonhistone substrates of
acetyltransferases and deacetylases, the enzymes that modulate their function. This obviously complicates the
contribution of each individual modification, and it willcatalyze the addition and removal of acetyl groups, re-
spectively. Numerous histone acetyltransferases (HATs) be important to sort out the order and dynamics of
multiple modification events on endogenous regulatoryand histone deacetylases (HDACs) are intimately associ-
ated with various components of the core transcriptional proteins (see Figure 1B). For example, the major site of
Sp3 sumoylation is identical to the major site of acetyla-machinery. For example, the TAF1 subunit of TFIID has
been shown to contain HAT activity, suggesting that it tion, and both of these modifications have been demon-
strated to modulate activation (Braun et al., 2001). Pre-may function to acetylate transcriptional components
in addition to histones (Mizzen et al., 1996). Accordingly, sumably, in such cases one modification may preclude
the other or alternatively may be responsible for en-the addition and removal of acetyl groups to and from
transcription factors will play as important a role in tran- hancement of a second modification at a nearby residue.
For example, sumoylation of a lysine residue in IBscriptional regulation as histone acetylation and deace-
tylation. For example, the HAT-containing coactivator has been demonstrated to block ubiquitnation at this
identical residue, protecting IB from proteasomal-p300 has been documented to acetylate the p53 tumor
suppressor protein thereby stimulating its function as mediated degradation (Desterro et al., 1998). In addition,
acetylation of the Smad7 transcriptional regulator hasan activator (Barlev et al., 2001; Gu and Roeder, 1997).
Thanos and colleagues have also demonstrated that the recently been shown to protect Smad7 from ubiquitin-
mediated degradation, suggesting a competition be-acetylation state of HMGI(Y) is critical for regulating
the assembly and disassembly of an enhancesome at tween ubiquitination and acetylation at critical lysine
residues (Gronroos et al., 2002). Likewise, it has beenthe IFN- gene, further underscoring the importance
of nonhistone acetylation in transcriptional regulation proposed that sumoylation of a specific lysine residue
may protect a given protein from ubiquitination and sub-(Munshi et al., 2001). Recently, Bereshchenko et al.
(2002) reported the ability of p300 to acetylate the sequent proteasomal-mediated proteolysis. It is not
hard to envision that these lysine residues thereforetranscriptional repressor BCL6. In this case, acetylation
inactivates the ability of BCL6 to recruit HDACs and serve as critical molecular switches that can respond
to different signals in highly specific ways. In addition,function as a potent repressor of transcription (Beresh-
chenko et al., 2002). Together, these studies illuminate since most proteins contain many lysine residues, tran-
scription factors may undergo multiple modificationsthe ability of HATs to either stimulate or inactivate the
function of nonhistone regulatory proteins. simultaneously or in sequential order, pointing to the
possibility of generating complex networks of regulatoryTranscriptional activation by the herpes simplex virus
(HSV) activator VP16 includes recruitment of HAT-con- events (see Figure 1B). Sorting out such a molecular
switch board, both biochemically and genetically, posestaining coactivator complexes to viral immediate-early
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a formidable but necessary task if we are to understand sion outcomes depending on the species. For example,
the transcription factor TFIID is largely conserved fromhow tissue-specific and gene-selective transcriptional
regulation is achieved. yeast to humans; however, the diverse programs of gene
expression regulated by this multiprotein coactivatorWhile the modifications described here all target ly-
sine residues, they are inherently quite different in the complex in unicellular and multicellular organisms have
diverged substantially. Therefore, it is possible that co-manner they alter target proteins. While acetylation en-
tails the addition of a relatively small, uncharged acetyl valent modification of transcription factors, like TFIID,
may occur in a species-specific manner, thereby al-group, addition of ubiquitin and SUMO involves at-
taching relatively large polypeptides that can signifi- lowing these factors to evolve specialized functions re-
lated to their evolutionary niche. For example, TFIIDcantly add to the mass of target proteins. Not surpris-
ingly, the functional outcomes resulting from these derived from animal cells containing cell type-specific
subunits may be modified by specific mechanisms spe-diverse covalent changes can be very different. One
can imagine that such biochemically distinct changes cialized to function in certain tissue types. Clearly, tran-
scription is exquisitely regulated in all organisms, andmediate important differences in the function of modi-
fied proteins. For example, some types of alterations one mechanism utilized to achieve such regulation is
covalent modification of the transcriptional machinery.may induce conformational changes while other modifi-
cations may trigger charge surface changes. The net Future studies in diverse organisms and specialized reg-
ulatory pathways should further illuminate how tran-outcomes, however, would be to disrupt and reorganize
important protein-protein and protein-DNA contacts. scription factor modification contributes to the elabo-
rate mechanisms of gene regulation.Documenting the biophysical changes in modified pro-
teins should help illuminate the function of these diverse
Referencesmodifications.
Albert, T.K., Hanzawa, H., Legtenberg, Y.I., de Ruwe, M.J., van den
Concluding Remarks Heuvel, F.A., Collart, M.A., Boelens, R., and Timmers, H.T. (2002).
The recent completion of several animal genome se- Identification of a ubiquitin-protein ligase subunit within the CCR4-
NOT transcription repressor complex. EMBO J. 21, 355–364.quences has revealed that the number of expressed
genes is considerably lower than expected. Conse- Barlev, N.A., Liu, L., Chehab, N.H., Mansfield, K., Harris, K.G., Hala-
zonetis, T.D., and Berger, S.L. (2001). Acetylation of p53 activatesquently, the vast differences in cell types, signal trans-
transcription through recruitment of coactivators/histone acetyl-duction pathways, and complex behaviors characteris-
transferases. Mol. Cell 8, 1243–1254.tic of different species cannot be easily explained by
Bereshchenko, O.R., Gu, W., and Dalla-Favera, R. (2002). Acetylationincreased gene number (i.e., worms, 19K and humans,
inactivates the transcriptional repressor BCL6. Nat. Genet. 32,
30K) alone but, rather, how a relatively limited number 606–613.
of genes (roughly 10–30K) are differentially expressed
Berger, S.L. (2002). Histone modifications in transcriptional regula-
and utilized. In other words, the dramatic phenotypic tion. Curr. Opin. Genet. Dev. 12, 142–148.
differences between a worm and a mammal can at least Best, J.L., Ganiatsas, S., Agarwal, S., Changou, A., Salomoni, P.,
partially be rationalized by differences in the complexity Shirihai, O., Meluh, P.B., Pandolfi, P.P., and Zon, L.I. (2002). SUMO-1
of the regulatory code and not merely gene content. protease-1 regulates gene transcription through PML. Mol. Cell 10,
843–855.The discovery of multiple covalent modifications of the
regulatory apparatus discussed here suggests that or- Bhaskar, V., Valentine, S.A., and Courey, A.J. (2000). A functional
interaction between dorsal and components of the Smt3 conjugationganisms have evolved various mechanisms to maximize
machinery. J. Biol. Chem. 275, 4033–4040.the usage of a relatively limited number of genes and
Bhaskar, V., Smith, M., and Courey, A.J. (2002). Conjugation of Smt3transcription factors. By utilizing multiple distinct mech-
to dorsal may potentiate the Drosophila immune response. Mol.anisms to modify and control the transcriptional machin-
Cell. Biol. 22, 492–504.
ery, organisms have evolved much greater potential for
Braun, H., Koop, R., Ertmer, A., Nacht, S., and Suske, G. (2001).directing diverse expression profiles by a finite number
Transcription factor Sp3 is regulated by acetylation. Nucleic Acids
of transcription factors. Taking advantage of multiple Res. 29, 4994–5000.
covalent modifications of transcription factors organ- Brivanlou, A.H., and Darnell, J.E., Jr. (2002). Signal transduction and
isms have effectively gained the ability to utilize the the control of gene expression. Science 295, 813–818.
same regulatory factor in different ways and thus expand Brower, C.S., Sato, S., Tomomori-Sato, C., Kamura, T., Pause, A.,
their range of gene expression patterns. Regulation by Stearman, R., Klausner, R.D., Malik, S., Lane, W.S., Sorokina, I., et
al. (2002). Mammalian mediator subunit mMED8 is an Elongin BC-modification not only enhances the functional potential
interacting protein that can assemble with Cul2 and Rbx1 to recon-of each individual transcription factor but also provides
stitute a ubiquitin ligase. Proc. Natl. Acad. Sci. USA 99, 10353–10358.an effective means of greatly amplifying the functional
Desterro, J.M., Rodriguez, M.S., and Hay, R.T. (1998). SUMO-1 modi-plasticity of the transcriptional machinery required for
fication of IkappaBalpha inhibits NF-kappaB activation. Mol. Cell 2,combinatorial diversity. This quantum increase in the
233–239.
repertoire of regulatory events ultimately provides the
Ferdous, A., Gonzalez, F., Sun, L., Kodadek, T., and Johnston, S.A.rich tapestry of molecular interactions necessary to di-
(2001). The 19S regulatory particle of the proteasome is required
rect the diverse arrays of gene expression programs for efficient transcription elongation by RNA polymerase II. Mol. Cell
that define complex organisms. 7, 981–991.
While many components of the transcriptional ma- Gonzalez, F., Delahodde, A., Kodadek, T., and Johnston, S.A. (2002).
chinery are conserved through evolution, we suspect Recruitment of a 19S proteasome subcomplex to an activated pro-
moter. Science 296, 548–550.that some modification networks may be specific to
individual organisms, resulting in different gene expres- Gronroos, E., Hellman, U., Heldin, C.H., and Ericsson, J. (2002).
Review
17
Control of Smad7 stability by competition between acetylation and
ubiquitination. Mol. Cell 10, 483–493.
Gu, W., and Roeder, R.G. (1997). Activation of p53 sequence-specific
DNA binding by acetylation of the p53 C-terminal domain. Cell 90,
595–606.
Hershko, A., and Ciechanover, A. (1998). The ubiquitin system. Annu.
Rev. Biochem. 67, 425–479.
Jenuwein, T., and Allis, C.D. (2001). Translating the histone code.
Science 293, 1074–1080.
Kaiser, P., Flick, K., Wittenberg, C., and Reed, S.I. (2000). Regulation
of transcription by ubiquitination without proteolysis: Cdc34/
SCF(Met30)-mediated inactivation of the transcription factor Met4.
Cell 102, 303–314.
Kim, K.I., Baek, S.H., and Chung, C.H. (2002). Versatile protein tag,
SUMO: its enzymology and biological function. J. Cell. Physiol. 191,
257–268.
Kuras, L., Rouillon, A., Lee, T., Barbey, R., Tyers, M., and Thomas, D.
(2002). Dual regulation of the met4 transcription factor by ubiquitin-
dependent degradation and inhibition of promoter recruitment. Mol.
Cell 10, 69–80.
Lee, K.B., Wang, D., Lippard, S.J., and Sharp, P.A. (2002). Transcrip-
tion-coupled and DNA damage-dependent ubiquitination of RNA
polymerase II in vitro. Proc. Natl. Acad. Sci. USA 99, 4239–4244.
Mizzen, C.A., Yang, X.J., Kokubo, T., Brownell, J.E., Bannister, A.J.,
Owen-Hughes, T., Workman, J., Wang, L., Berger, S.L., Kouzarides,
T., et al. (1996). The TAF(II)250 subunit of TFIID has histone acetyl-
transferase activity. Cell 87, 1261–1270.
Molinari, E., Gilman, M., and Natesan, S. (1999). Proteasome-medi-
ated degradation of transcriptional activators correlates with activa-
tion domain potency in vivo. EMBO J. 18, 6439–6447.
Munshi, N., Agalioti, T., Lomvardas, S., Merika, M., Chen, G., and
Thanos, D. (2001). Coordination of a transcriptional switch by
HMGI(Y) acetylation. Science 293, 1133–1136.
Pham, A.D., and Sauer, F. (2000). Ubiquitin-activating/conjugating
activity of TAFII250, a mediator of activation of gene expression in
Drosophila. Science 289, 2357–2360.
Ross, S., Best, J.L., Zon, L.I., and Gill, G. (2002). SUMO-1 modifica-
tion represses Sp3 transcriptional activation and modulates its sub-
nuclear localization. Mol. Cell 10, 831–842.
Rouillon, A., Barbey, R., Patton, E.E., Tyers, M., and Thomas, D.
(2000). Feedback-regulated degradation of the transcriptional acti-
vator Met4 is triggered by the SCF(Met30)complex. EMBO J. 19,
282–294.
Sachdev, S., Bruhn, L., Sieber, H., Pichler, A., Melchior, F., and
Grosschedl, R. (2001). PIASy, a nuclear matrix-associated SUMO
E3 ligase, represses LEF1 activity by sequestration into nuclear
bodies. Genes Dev. 15, 3088–3103.
Salghetti, S.E., Muratani, M., Wijnen, H., Futcher, B., and Tansey,
W.P. (2000). Functional overlap of sequences that activate transcrip-
tion and signal ubiquitin-mediated proteolysis. Proc. Natl. Acad. Sci.
USA 97, 3118–3123.
Salghetti, S.E., Caudy, A.A., Chenoweth, J.G., and Tansey, W.P.
(2001). Regulation of transcriptional activation domain function by
ubiquitin. Science 293, 1651–1653.
Sapetschnig, A., Rischitor, G., Braun, H., Doll, A., Schergaut, M.,
Melchior, F., and Suske, G. (2002). Transcription factor Sp3 is si-
lenced through SUMO modification by PIAS1. EMBO J. 21, 5206–
5215.
Woudstra, E.C., Gilbert, C., Fellows, J., Jansen, L., Brouwer, J.,
Erdjument-Bromage, H., Tempst, P., and Svejstrup, J.Q. (2002). A
Rad26-Def1 complex coordinates repair and RNA pol II proteolysis
in response to DNA damage. Nature 415, 929–933.
Xu, W., Chen, H., Du, K., Asahara, H., Tini, M., Emerson, B.M., Mont-
miny, M., and Evans, R.M. (2001). A transcriptional switch mediated
by cofactor methylation. Science 294, 2507–2511.
